Nichole Tucker

Nichole Tucker, MA, is the Senior Editor for Targeted Oncology and host of the Targeted Talks podcast. Tucker received her Bachelor of Arts in Mass Communications from Virginia State University and her Master of Arts in Media & International Conflict from University College Dublin.

Articles by Nichole Tucker

FDA Approved | Image credit: chrisdorney - stock.adobe.com

FDA Approves Bosutinib for Pediatric Patients With CP-CML

ByNichole Tucker

October 27th 2023

Bosutinib has a new indication in leukemia as a well as a newly-approved formulation.

Pembrolizumab Sustains Efficacy at 5 Years in First-Line, PD-L1+, Advanced NSCLC

ByNichole Tucker

July 15th 2023

Findings from the 5-year follow-up analysis of the phase 3 KEYNOTE-042 study continue to support frontline pembrolizumab as standard of care for PD-L1-positive, locally advanced/metastatic non–small cell lung cancer (NSCLC).

Nichole Tucker

Articles by Nichole Tucker

FDA Approves Bosutinib for Pediatric Patients With CP-CML

Pembrolizumab Sustains Efficacy at 5 Years in First-Line, PD-L1+, Advanced NSCLC

Latest Updated Articles

Trending on AJMC

Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled

New WHO Reports Sounds Alarm on Antimicrobial Resistance

Value-Based Care Offers Solutions to Patient Access Challenges: Brian Mulherin, MD

Responsible Use of Energy-Based Treatments on Skin of Color: Eliot F. Battle, MD

Why Education and Collaboration Are Key to Bispecific Therapy Administration: Amir Fathi, MD